Induction of Th1 type response by DNA vaccinations with N, M, and E genes against SARS-CoV in mice

[1]  T. Greenough,et al.  What’s new in the renin-angiotensin system? , 2004, Cellular and Molecular Life Sciences CMLS.

[2]  Fuchun Zhang,et al.  Effect of chemical adjuvants on DNA vaccination. , 2004, Vaccine.

[3]  Tae Woo Kim,et al.  Generation and Characterization of DNA Vaccines Targeting the Nucleocapsid Protein of Severe Acute Respiratory Syndrome Coronavirus , 2004, Journal of Virology.

[4]  K. Tao,et al.  Induction of SARS-nucleoprotein-specific immune response by use of DNA vaccine , 2004, Immunology Letters.

[5]  A. Hill,et al.  Prime-boost strategies for malaria vaccine development , 2003, Journal of Experimental Biology.

[6]  W. Akahata,et al.  DNA vaccination of macaques by a full-genome simian/human immunodeficiency virus type 1 plasmid chimera that produces non-infectious virus particles. , 2003, The Journal of general virology.

[7]  I. M. Belyakov,et al.  DNA vaccines encoding human immunodeficiency virus-1 glycoprotein 120 fusions with proinflammatory chemoattractants induce systemic and mucosal immune responses. , 2002, Blood.

[8]  G. Trinchieri,et al.  Effect of the V3 Loop Deletion of Envelope Glycoprotein on Cellular Responses and Protection against Challenge with Recombinant Vaccinia Virus Expressing gp160 of Primary Human Immunodeficiency Virus Type 1 Isolates , 2002, Journal of Virology.

[9]  Scott N. Mueller,et al.  Progression of Armed CTL from Draining Lymph Node to Spleen Shortly After Localized Infection with Herpes Simplex Virus 11 , 2002, The Journal of Immunology.

[10]  J. Ulmer,et al.  Induction of Potent Immune Responses by Cationic Microparticles with Adsorbed Human Immunodeficiency Virus DNA Vaccines , 2001, Journal of Virology.

[11]  M. K. Hart,et al.  Protection from Ebola Virus Mediated by Cytotoxic T Lymphocytes Specific for the Viral Nucleoprotein , 2001, Journal of Virology.

[12]  K. Brahimi,et al.  DNA Immunization by Plasmodium falciparum Liver-Stage Antigen 3 Induces Protection againstPlasmodium yoelii Sporozoite Challenge , 2001, Infection and Immunity.

[13]  H. McShane,et al.  Enhanced Immunogenicity of CD4+ T-Cell Responses and Protective Efficacy of a DNA-Modified Vaccinia Virus Ankara Prime-Boost Vaccination Regimen for Murine Tuberculosis , 2001, Infection and Immunity.

[14]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[15]  F. Chisari,et al.  Targeting Murine Immune Responses to Selected T Cell- or Antibody-Defined Determinants of the Hepatitis B Surface Antigen by Plasmid DNA Vaccines Encoding Chimeric Antigen1 , 2001, The Journal of Immunology.

[16]  F. Lemonnier,et al.  Multiepitopic HLA-A*0201-Restricted Immune Response Against Hepatitis B Surface Antigen After DNA-Based Immunization , 2000, The Journal of Immunology.

[17]  S. Hoffman,et al.  Improving Protective Immunity Induced by DNA-Based Immunization: Priming with Antigen and GM-CSF-Encoding Plasmid DNA and Boosting with Antigen-Expressing Recombinant Poxvirus1 2 , 2000, The Journal of Immunology.

[18]  J. Stephenson,et al.  CTL epitopes identified with a defective recombinant adenovirus expressing measles virus nucleoprotein and evaluation of their protective capacity in mice. , 1999, Virus research.

[19]  T. Kurata,et al.  Protection and antibody responses in different strains of mouse immunized with plasmid DNAs encoding influenza virus haemagglutinin, neuraminidase and nucleoprotein. , 1999, The Journal of general virology.

[20]  F. Ennis,et al.  Human Memory Cytotoxic T-Lymphocyte (CTL) Responses to Hantaan Virus Infection: Identification of Virus-Specific and Cross-Reactive CD8+ CTL Epitopes on Nucleocapsid Protein , 1999, Journal of Virology.

[21]  Hidehiro Takahashi,et al.  Enhanced protection against a lethal influenza virus challenge by immunization with both hemagglutinin- and neuraminidase-expressing DNAs. , 1999, Vaccine.

[22]  S Oehen,et al.  Differentiation of naive CTL to effector and memory CTL: correlation of effector function with phenotype and cell division. , 1998, Journal of immunology.

[23]  R. Webster,et al.  Protection of ferrets against influenza challenge with a DNA vaccine to the haemagglutinin. , 1994, Vaccine.

[24]  D B Corry,et al.  Constructing polycompetitor cDNAs for quantitative PCR. , 1993, Journal of immunological methods.

[25]  J. Ulmer,et al.  Heterologous protection against influenza by injection of DNA encoding a viral protein. , 1993, Science.

[26]  H. Laude,et al.  Single amino acid changes in the viral glycoprotein M affect induction of alpha interferon by the coronavirus transmissible gastroenteritis virus , 1992, Journal of virology.

[27]  H. Vennema,et al.  Early death after feline infectious peritonitis virus challenge due to recombinant vaccinia virus immunization , 1990, Journal of virology.

[28]  H. Laude,et al.  Induction of alpha interferon by transmissible gastroenteritis coronavirus: role of transmembrane glycoprotein E1 , 1988, Journal of virology.

[29]  F. Scott,et al.  Antibody-mediated enhancement of disease in feline infectious peritonitis: Comparisons with dengue hemorrhagic fever☆ , 1981, Comparative Immunology, Microbiology and Infectious Diseases.

[30]  John M. Walker,et al.  DNA Vaccines , 2006, Methods in Molecular Medicine™.

[31]  Marian C. Horzinek,et al.  Adverse effects of feline IL-12 during DNA vaccination against feline infectious peritonitis virus. , 2002, The Journal of general virology.

[32]  S. Gurunathan,et al.  DNA vaccines: immunology, application, and optimization*. , 2000, Annual review of immunology.